Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02054117 · ClinicalTrials.gov registry record
Association Between Haptoglobin Genotype and Brain Swelling
A clinical trial, sponsored by University of Florida.
- Terminated
- Registry status
- 9
- Enrollment target
NCT02054117 is a clinical trial that was terminated before completion, run by University of Florida. The registered enrollment target is 9 participants.
The verdict
NCT02054117 was terminated before completion, sponsored by University of Florida.
- TERMINATED
- Registry status
- 9 participants
- Enrollment target
Study Summary
Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain swelling develops causing further compression that may lead to brain herniation and death. This study investigates the neuroprotective role of haptoglobin, in minimizing the development of brain swelling following intracerebral hemorrhage.
Interventions
- OTHER Intracerebral Hemorrhage
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2014-03 |
| Est. Completion | 2015-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02054117
The ClinicalTrials.gov registry entry for NCT02054117 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Intracerebral Hemorrhage is the first listed.
NCT02054117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02054117 about?
NCT02054117 is a clinical study titled "Association Between Haptoglobin Genotype and Brain Swelling". Intracerebral hemorrhage is bleeding into the brain and is a major cause of stroke and other complications. Brain injury from intracerebral hemorrhage occurs in two phases. The early phase involves the mechanical compression of brain tissue by the expanding hematoma. In a later phase, brain swelling...
What is the current status of trial NCT02054117?
This trial is currently terminated. The enrollment target is 9 participants. The study started on 2014-03. Estimated completion is 2015-03.
What interventions are being tested in trial NCT02054117?
The interventions under investigation include: Intracerebral Hemorrhage (OTHER).
Who is sponsoring clinical trial NCT02054117?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.